Sun Yongxu, Liu Jicheng
Department of Pharmacology, Qiqihar Medical University, Qiqihar 161042, China.
Vaccine. 2008 Jul 23;26(31):3932-6. doi: 10.1016/j.vaccine.2008.04.018. Epub 2008 Apr 28.
In our previous work, a new water-soluble polysaccharide (PAP) from the mycelium of Polyporus albicans was identified for the first time. Preliminary tests in vitro showed PAP have potent stimulating effects on murine lymphocyte proliferation induced by mitogen. So in this study, the immunomodulatory effect and the adjuvant potential of PAP on the cellular and humoral immune response of ICR mice against ovalbumin were investigated. In vivo toxicity assays of PAP showed not to be lethal for mice in doses ranging from 0.5 to 4 mg. ICR mice were immunized subcutaneously with OVA 0.1 mg alone or with OVA 0.1 mg dissolved in saline containing alum (0.2 mg) or PAP (0.5, 1 and 2 mg) on days 1 and 15. Two weeks later (day 28), concanavalin A (Con A)-, lipopolysaccharide (LPS)- and OVA-stimulated splenocyte proliferation and OVA-specific serum antibodies were measured. PAP (0.5, 1 and 2 mg) other than alum significantly enhanced the Con A-, LPS- or OVA-induced splenocyte proliferation in the OVA-immunized mice (P<0.05 or <0.01). The OVA-specific IgG, IgG1 and IgG2b antibody levels in serum were also significantly enhanced by PAP (0.5, 1 and 2 mg) compared with OVA control group (P<0.05 or <0.01). Moreover, alum (0.2 mg) only induces IgG and IgG1 antibody responses to OVA in mice. In conclusion, the results suggest that PAP could be a safe efficacious adjuvant capable of boosting cellular and humoral immunity without unacceptable toxicity. Thus adjuvants based on PAP have enormous potential for use in vaccines against both pathogens and cancer.
在我们之前的工作中,首次从白拟多孔菌菌丝体中鉴定出一种新的水溶性多糖(PAP)。体外初步试验表明,PAP对丝裂原诱导的小鼠淋巴细胞增殖具有显著的刺激作用。因此,在本研究中,研究了PAP对ICR小鼠针对卵清蛋白的细胞免疫和体液免疫反应的免疫调节作用及佐剂潜力。PAP的体内毒性试验表明,剂量在0.5至4mg范围内对小鼠无致死性。在第1天和第15天,将ICR小鼠皮下注射单独的0.1mg卵清蛋白,或溶解于含明矾(0.2mg)或PAP(0.5、1和2mg)的盐水中的0.1mg卵清蛋白。两周后(第28天),检测伴刀豆球蛋白A(Con A)、脂多糖(LPS)和卵清蛋白刺激的脾细胞增殖以及卵清蛋白特异性血清抗体。与明矾不同,PAP(0.5、1和2mg)显著增强了卵清蛋白免疫小鼠中Con A、LPS或卵清蛋白诱导的脾细胞增殖(P<0.05或<0.01)。与卵清蛋白对照组相比,PAP(0.5、1和2mg)也显著提高了血清中卵清蛋白特异性IgG、IgG1和IgG2b抗体水平(P<0.05或<0.01)。此外,明矾(0.2mg)仅诱导小鼠对卵清蛋白产生IgG和IgG1抗体反应。总之,结果表明PAP可能是一种安全有效的佐剂,能够增强细胞免疫和体液免疫,且无不可接受的毒性。因此,基于PAP的佐剂在针对病原体和癌症的疫苗中具有巨大的应用潜力。